164 related articles for article (PubMed ID: 37672865)
1. Anti-Interleukin-17s for successful management of pustular psoriasis.
Guerra P; Rosi E; Scandagli I; Silvi G; Nunziati G; Di Cesare A; Prignano F
Cytokine; 2023 Nov; 171():156353. PubMed ID: 37672865
[TBL] [Abstract][Full Text] [Related]
2. Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review.
Rosi E; Fastame MT; Di Cesare A; Prignano F
Expert Opin Biol Ther; 2022 Dec; 22(12):1475-1487. PubMed ID: 35997143
[TBL] [Abstract][Full Text] [Related]
3. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities?
Chularojanamontri L; Rattanakorn K; Julanon N; Chuamanochan M; Griffiths CEM
Exp Dermatol; 2023 Aug; 32(8):1235-1245. PubMed ID: 37057764
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
[TBL] [Abstract][Full Text] [Related]
5. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
6. Pustular Psoriasis: From Pathophysiology to Treatment.
Genovese G; Moltrasio C; Cassano N; Maronese CA; Vena GA; Marzano AV
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944562
[TBL] [Abstract][Full Text] [Related]
7. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
[TBL] [Abstract][Full Text] [Related]
8. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
9. Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.
Cirone KD; Lovegrove FE
SAGE Open Med Case Rep; 2023; 11():2050313X231160937. PubMed ID: 36968989
[TBL] [Abstract][Full Text] [Related]
10. Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.
Samotij D; Gawron E; Szczęch J; Ostańska E; Reich A
Biologics; 2021; 15():107-113. PubMed ID: 33948082
[TBL] [Abstract][Full Text] [Related]
11. Acrodermatitis continua of Hallopeau is a clinical phenotype of DITRA: evidence that it is a variant of pustular psoriasis.
Abbas O; Itani S; Ghosn S; Kibbi AG; Fidawi G; Farooq M; Shimomura Y; Kurban M
Dermatology; 2013; 226(1):28-31. PubMed ID: 23428889
[TBL] [Abstract][Full Text] [Related]
12. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
13. Acute Generalized Pustular Psoriasis Developed Resistance to Adalimumab Was Successfully Treated with Narrowband Ultraviolet B and Acitretin: A Case Report.
Yang X; Wang J; Wang H; Kong M; Chen Q
Clin Cosmet Investig Dermatol; 2022; 15():2541-2546. PubMed ID: 36466946
[TBL] [Abstract][Full Text] [Related]
14. Acrodermatitis continua of Hallopeau: clinical perspectives.
Smith MP; Ly K; Thibodeaux Q; Bhutani T; Liao W; Beck KM
Psoriasis (Auckl); 2019; 9():65-72. PubMed ID: 31497529
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
16. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
[TBL] [Abstract][Full Text] [Related]
17. Pustular psoriasis: pathophysiology and current treatment perspectives.
Benjegerdes KE; Hyde K; Kivelevitch D; Mansouri B
Psoriasis (Auckl); 2016; 6():131-144. PubMed ID: 29387600
[TBL] [Abstract][Full Text] [Related]
18. Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab.
Herrero-Moyano M; Capusan TM; Martínez-Mera C; Llamas-Velasco M; Daudén E
JAAD Case Rep; 2018 Sep; 4(8):842-844. PubMed ID: 30246137
[No Abstract] [Full Text] [Related]
19. Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled.
Coscarella G; Falco GM; Palmisano G; Ippoliti E; De Luca E; Gori N; Di Nardo L; Caldarola G; De Simone C; Chiricozzi A; Peris K
Front Med (Lausanne); 2023; 10():1295973. PubMed ID: 38274451
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report.
Nguyen A; D'Aguanno K; Ridha Z; Tsoukas A; Netchiporouk E
SAGE Open Med Case Rep; 2023; 11():2050313X231180775. PubMed ID: 37359284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
